Deep vein thrombosis associated with central venous catheters – a review

Central venous catheter-related thrombosis in intensive care patients - incidence and risk factors: A prospective observational study

“…Deep vein thrombosis is one of the complications described during central vein cannulation 1,3 . In our study we diagnosed thrombosis following CVC extraction in 47 (24%) patients, which is in agreement with other studies concerning the topic 9,10 . Risk of CR-DVT is higher when CVC is inserted in IJV than in SCV (ref.…”

Deep Vein Thrombosis of the Arms

“…cancer) risk factors. In intensive care patients as well as in patients suffering from malignant disease with central venous catheters, rates of asymptomatic thrombosis as high as 30% to over 60% have been reported (Timsit et al, 1998;Van Rooden et al, 2005). There appears to be an increase in upper extremity deep vein thrombosis in the last decades, which may reflect the increasing use of central venous catheters (S. Mustafa et al, 2003;Czihal & Hoffmann, 2011), improved diagnostic methods, or both.…”

“…This large variation in risk may in part be explained by specific features of the central venous catheter, as e.g. catheter type and material, site, technique and level of insertion as reviewed by Van Rooden et al, 2005. Additional factors that have an impact on the risk of thrombosis in patients with central venous catheters include the number of punctures during catheter insertion, the duration of catheterization, the fluid administered, and catheter related infections (Koksoy et al, 1995;Hernandez et al, 1998;Martin et al, 1999).…”

“…Patients with central venous catheters carry a high risk of deep arm vein thrombosis, which may exceed 60 % in certain patient groups (ICU patients, oncological and hematological patients) Van Rooden et al, 2005. Therefore, approaches to prevent catheter-related thrombosis by means of pharmacological prophylaxis e.g.…”

Venous Thromboembolism Prophylaxis in Cancer Patients

“…Central catheter per se is a risk factor for VTE, this risk is even higher when such catheters are placed in cancer patients especially so when used for active chemotherapy (Bona, 1999;Rooden et al, 2005;Rosovsky & Kuter, 2005). Several clinical trials have addressed the issue of VTE prophylaxis in such patients.…”